Skriftligt spörsmål om uppföljning av konsekvenserna för den sänkta ersättningsnivån för diabetesläkemedel

This question asks about the follow-up of consequences stemming from a reduction in reimbursement levels for diabetes medications. It seeks to understand the impact of these changes on patients and the healthcare system. The question specifically addresses how the reduced reimbursement affects access to essential diabetes treatments and whether this impacts equality in healthcare access for affected individuals.